VITAMIN C

VITAMIN C was reported 93334 times

VITAMIN C is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 102 0.5152
1 C-REACTIVE PROTEIN 397 0.4283
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 820 0.4094
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 269 0.4027
4 LUPUS VULGARIS 504 0.4000
5 APPENDICOLITH 150 0.3876
6 RHEUMATIC FEVER 1573 0.3525
7 SWOLLEN JOINT COUNT INCREASED 1106 0.3465
8 SWOLLEN JOINT COUNT 85 0.3400
9 FACET JOINT SYNDROME 1084 0.3326
10 GRIP STRENGTH 71 0.3100
11 ANALGESIC THERAPY 98 0.3053
12 EJECTION FRACTION 167 0.2874
13 HYPOCHOLESTEROLAEMIA 101 0.2861
14 X-RAY ABNORMAL 498 0.2782
15 SENSITISATION 207 0.2727
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 148 0.2638
17 DRUG THERAPY 87 0.2566
18 PERIPHERAL VENOUS DISEASE 989 0.2419
19 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 492 0.2372
20 DUODENAL ULCER PERFORATION 1740 0.2337
21 RETINITIS 387 0.2238
22 DISLOCATION OF VERTEBRA 496 0.2173
23 RHEUMATOID FACTOR POSITIVE 1220 0.2110
24 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1503 0.2096
25 TEMPERATURE REGULATION DISORDER 439 0.1969
26 C-REACTIVE PROTEIN ABNORMAL 1177 0.1833
27 MUSCLE INJURY 1500 0.1809
28 HELICOBACTER INFECTION 1766 0.1717
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1104 0.1698
30 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 74 0.1612
31 FOLLICULITIS 1672 0.1593
32 PEMPHIGUS 1993 0.1592
33 HAND DEFORMITY 1857 0.1414
34 OVERLAP SYNDROME 99 0.1414
35 POLYCYSTIC OVARIES 211 0.1360
36 LIP DRY 1216 0.1337
37 PORPHYRIA ACUTE 180 0.1254
38 BURSITIS 1488 0.1225
39 BREAST CANCER STAGE III 763 0.1177
40 PERICARDITIS 1909 0.1135
41 BONE EROSION 395 0.1116
42 ONYCHOMADESIS 467 0.1112
43 SYNOVITIS 1947 0.1079
44 JOINT RANGE OF MOTION DECREASED 1338 0.0997
45 BLEPHAROSPASM 615 0.0976
46 SERONEGATIVE ARTHRITIS 109 0.0951
47 GLOSSODYNIA 2123 0.0947
48 LIVE BIRTH 753 0.0899
49 WOUND INFECTION 977 0.0891
50 AUTOIMMUNE DISORDER 854 0.0875
51 HYPERCHOLESTEROLAEMIA 841 0.0870
52 GRIP STRENGTH DECREASED 751 0.0852
53 FIBROMYALGIA 1987 0.0817
54 IRRITABLE BOWEL SYNDROME 1745 0.0813
55 WOUND 2179 0.0779
56 FOOD ALLERGY 590 0.0764
57 ONYCHOMYCOSIS 315 0.0717
58 DRUG TOLERANCE DECREASED 193 0.0687
59 INFUSION SITE REACTION 201 0.0672
60 MATERNAL EXPOSURE TIMING UNSPECIFIED 252 0.0670
61 CONTRAINDICATED PRODUCT ADMINISTERED 2031 0.0670
62 SCIATICA 1065 0.0667
63 LIVER INJURY 1629 0.0663
64 OBSTRUCTIVE SLEEP APNOEA SYNDROME 96 0.0658
65 OBESITY 1034 0.0648
66 COELIAC DISEASE 635 0.0647
67 PRESCRIBED OVERDOSE 1188 0.0613
68 SEDATION COMPLICATION 155 0.0607
69 IMPAIRED HEALING 1981 0.0603
70 SYSTEMIC LUPUS ERYTHEMATOSUS 2131 0.0600
71 EJECTION FRACTION ABNORMAL 73 0.0595
72 NAIL DISORDER 517 0.0590
73 HYPERPHOSPHATAEMIA 127 0.0590
74 RHINITIS ALLERGIC 257 0.0577
75 NEPHRECTOMY 85 0.0572
76 TYPE 2 DIABETES MELLITUS 1904 0.0565
77 EXOSTOSIS 516 0.0564
78 PSORIATIC ARTHROPATHY 2226 0.0548
79 NIGHT SWEATS 1754 0.0544
80 LOWER LIMB FRACTURE 1009 0.0525
81 ULCER HAEMORRHAGE 348 0.0514
82 BLOOD PHOSPHORUS INCREASED 139 0.0509
83 FINGER DEFORMITY 244 0.0503
84 IMMUNODEFICIENCY 749 0.0502
85 BLOOD PRESSURE SYSTOLIC ABNORMAL 120 0.0485
86 FOETAL DEATH 249 0.0480
87 WALKING AID USER 316 0.0479
88 INFUSION SITE DISCHARGE 83 0.0473
89 TASTE DISORDER 912 0.0449
90 EYE INJURY 136 0.0447
91 BLOOD CHOLESTEROL INCREASED 2072 0.0444
92 GAIT INABILITY 1482 0.0443
93 PUSTULAR PSORIASIS 151 0.0439
94 RED BLOOD CELL SEDIMENTATION RATE INCREASED 484 0.0437
95 ESSENTIAL HYPERTENSION 80 0.0437
96 BLOOD PRESSURE DIASTOLIC ABNORMAL 111 0.0436
97 INFUSION RELATED REACTION 2880 0.0434
98 MUSCLE SPASTICITY 526 0.0428
99 BACK INJURY 465 0.0427
100 LOWER RESPIRATORY TRACT INFECTION 1941 0.0426
101 LUPUS-LIKE SYNDROME 387 0.0426
102 INFUSION SITE BRUISING 92 0.0426
103 ARTHROPATHY 2316 0.0416
104 CREATININE RENAL CLEARANCE DECREASED 166 0.0414
105 PULMONARY FIBROSIS 794 0.0413
106 OSTEOARTHRITIS 1688 0.0398
107 BREAST CANCER STAGE II 331 0.0397
108 EAR PAIN 773 0.0397
109 HEPATIC ENZYME INCREASED 2709 0.0397
110 INFUSION SITE PRURITUS 122 0.0386
111 EYELID PAIN 76 0.0374
112 FOOT DEFORMITY 407 0.0367
113 RASH VESICULAR 176 0.0364
114 STOMATITIS 2206 0.0363
115 BLISTER 2026 0.0360
116 SPONDYLITIS 131 0.0360
117 THERAPEUTIC PRODUCT EFFECT DECREASED 1570 0.0350
118 WHEEZING 2051 0.0346
119 HIP ARTHROPLASTY 521 0.0340
120 PRODUCT LABEL CONFUSION 198 0.0339
121 INFUSION SITE HAEMORRHAGE 111 0.0337
122 LYMPHADENITIS 80 0.0330
123 SEASONAL ALLERGY 454 0.0320
124 MOBILITY DECREASED 2254 0.0313
125 SKIN ABRASION 148 0.0313
126 IRON DEFICIENCY 139 0.0309
127 BLOOD TEST ABNORMAL 433 0.0308
128 MUSCULOSKELETAL PAIN 1614 0.0308
129 HYPERPARATHYROIDISM SECONDARY 77 0.0307
130 CHRONIC SINUSITIS 115 0.0306
131 LUNG DISORDER 1499 0.0306
132 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 518 0.0305
133 NEPHROGENIC ANAEMIA 141 0.0304
134 AORTIC STENOSIS 104 0.0298
135 MULTIPLE ALLERGIES 234 0.0298
136 SINUSITIS 3059 0.0298
137 PRESCRIBED UNDERDOSE 594 0.0297
138 RHEUMATOID ARTHRITIS 3378 0.0297
139 JOINT SWELLING 3588 0.0297
140 JOINT DISLOCATION 314 0.0297
141 ROAD TRAFFIC ACCIDENT 1238 0.0296
142 FUNCTIONAL GASTROINTESTINAL DISORDER 101 0.0292
143 SWELLING 2734 0.0292
144 DISCOMFORT 1776 0.0291
145 SLEEP DISORDER 2051 0.0290
146 CONGENITAL ANOMALY 223 0.0288
147 INFLAMMATION 1484 0.0287
148 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 484 0.0282
149 CARPAL TUNNEL SYNDROME 394 0.0281
150 INFUSION SITE SWELLING 177 0.0281
151 HEPATIC CIRRHOSIS 525 0.0279
152 FULL BLOOD COUNT ABNORMAL 295 0.0279
153 C-REACTIVE PROTEIN INCREASED 999 0.0274
154 DRY MOUTH 2226 0.0274
155 UPPER RESPIRATORY TRACT INFECTION 1258 0.0272
156 BLOOD URIC ACID INCREASED 157 0.0272
157 KNEE ARTHROPLASTY 571 0.0271
158 REBOUND ACID HYPERSECRETION 82 0.0271
159 NORMAL NEWBORN 147 0.0270
160 RESPIRATORY SYMPTOM 75 0.0263
161 INJURY 1827 0.0260
162 ILL-DEFINED DISORDER 1561 0.0257
163 MUSCULOSKELETAL STIFFNESS 2250 0.0257
164 OEDEMA 1370 0.0252
165 THERAPY NON-RESPONDER 1129 0.0251
166 LIVER DISORDER 1111 0.0250
167 SLEEP APNOEA SYNDROME 478 0.0250
168 BODY TEMPERATURE INCREASED 511 0.0250
169 WEIGHT FLUCTUATION 262 0.0250
170 INFUSION SITE PAIN 322 0.0250
171 DRUG INTOLERANCE 2411 0.0249
172 LIVER FUNCTION TEST INCREASED 531 0.0247
173 GASTROOESOPHAGEAL REFLUX DISEASE 1977 0.0245
174 RESPIRATORY DISORDER 731 0.0244
175 INFUSION SITE ERYTHEMA 206 0.0244
176 EAR INFECTION 649 0.0244
177 BLOOD CALCIUM DECREASED 269 0.0239
178 MYASTHENIA GRAVIS 192 0.0237
179 PERIPHERAL SWELLING 3640 0.0236
180 SPINAL FUSION SURGERY 95 0.0234
181 INTENTIONAL PRODUCT USE ISSUE 2038 0.0232
182 RENAL FUNCTION TEST ABNORMAL 108 0.0232
183 TREATMENT FAILURE 1916 0.0231
184 CARBOHYDRATE ANTIGEN 125 INCREASED 78 0.0228
185 HYPOPHOSPHATAEMIA 168 0.0227
186 GASTROINTESTINAL DISORDER 2035 0.0227
187 CONTUSION 2182 0.0226
188 PARANASAL SINUS DISCOMFORT 85 0.0224
189 EXPOSURE DURING PREGNANCY 1377 0.0221
190 JOINT STIFFNESS 577 0.0220
191 PRE-EXISTING CONDITION IMPROVED 135 0.0216
192 FLUID RETENTION 1093 0.0215
193 GENERAL SYMPTOM 160 0.0213
194 PREGNANCY 425 0.0212
195 VASCULAR DEVICE INFECTION 96 0.0211
196 ASTHMA 2373 0.0210
197 HYPOAESTHESIA 3098 0.0207
198 ABDOMINAL DISCOMFORT 3449 0.0205
199 APPENDICITIS 191 0.0204
200 NASOPHARYNGITIS 3764 0.0204
201 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 977 0.0203
202 FREQUENT BOWEL MOVEMENTS 549 0.0203
203 TRIGGER FINGER 83 0.0203
204 ONYCHOCLASIS 139 0.0202
205 PARANASAL SINUS HYPERSECRETION 77 0.0202
206 MATERNAL EXPOSURE DURING PREGNANCY 1780 0.0200
207 OSTEOPOROSIS 811 0.0197
208 BENIGN PROSTATIC HYPERPLASIA 101 0.0195
209 VARICOSE VEIN 101 0.0195
210 MYOSITIS 175 0.0195
211 EPILEPSY 594 0.0194
212 GENERAL PHYSICAL HEALTH DETERIORATION 2230 0.0193
213 MIGRAINE 1832 0.0192
214 TONGUE DISCOMFORT 81 0.0191
215 UPPER-AIRWAY COUGH SYNDROME 157 0.0190
216 DRUG-INDUCED LIVER INJURY 597 0.0190
217 THROAT CLEARING 71 0.0189
218 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 95 0.0187
219 BLOOD IRON DECREASED 222 0.0187
220 BLOOD PRESSURE DIASTOLIC INCREASED 86 0.0186
221 ADVERSE REACTION 247 0.0186
222 INCREASED TENDENCY TO BRUISE 171 0.0186
223 HYPERLIPIDAEMIA 222 0.0186
224 BLOOD PRESSURE DIASTOLIC DECREASED 136 0.0184
225 NECK PAIN 1021 0.0183
226 NEURALGIA 444 0.0182
227 TENDON PAIN 138 0.0182
228 DYSPEPSIA 1782 0.0181
229 GLUCOSE TOLERANCE IMPAIRED 107 0.0181
230 PRODUCT ADMINISTRATION INTERRUPTED 142 0.0181
231 BLOOD CALCIUM INCREASED 158 0.0180
232 RED BLOOD CELL COUNT DECREASED 513 0.0179
233 SINUS CONGESTION 242 0.0179
234 MICTURITION URGENCY 204 0.0178
235 SINUS DISORDER 349 0.0176
236 BACK DISORDER 285 0.0175
237 VITAMIN D DECREASED 149 0.0174
238 ALOPECIA 3418 0.0174
239 HYPERTENSION 3680 0.0174
240 URTICARIA 2907 0.0173
241 PERIORBITAL SWELLING 98 0.0173
242 INFECTION 2508 0.0173
243 BODY HEIGHT DECREASED 185 0.0173
244 DISABILITY 342 0.0173
245 SPINAL STENOSIS 71 0.0172
246 HYPERSENSITIVITY 3191 0.0172
247 RASH ERYTHEMATOUS 817 0.0171
248 VENTRICULAR FIBRILLATION 188 0.0169
249 NOCTURIA 205 0.0169
250 FULL BLOOD COUNT DECREASED 340 0.0169
251 SKIN LACERATION 183 0.0168
252 DELIRIUM 583 0.0168
253 WEIGHT INCREASED 3760 0.0168
254 END STAGE RENAL DISEASE 306 0.0168
255 FAECES SOFT 122 0.0168
256 FOOT OPERATION 83 0.0168
257 ABDOMINAL PAIN UPPER 3452 0.0167
258 GASTROINTESTINAL PAIN 183 0.0166
259 MUSCULAR WEAKNESS 1881 0.0165
260 ROSACEA 77 0.0165
261 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1163 0.0163
262 SKIN ATROPHY 94 0.0163
263 CONFUSIONAL STATE 2637 0.0163
264 TUMOUR MARKER INCREASED 78 0.0162
265 HEPATIC ENZYME ABNORMAL 81 0.0162
266 BLOOD MAGNESIUM DECREASED 139 0.0161
267 EYE PAIN 902 0.0160
268 MEMORY IMPAIRMENT 2183 0.0159
269 MUSCLE SPASMS 2908 0.0158
270 URINE ABNORMALITY 72 0.0158
271 BREATH SOUNDS ABNORMAL 78 0.0158
272 CYSTITIS 503 0.0158
273 DECREASED IMMUNE RESPONSIVENESS 155 0.0158
274 OCULAR DISCOMFORT 176 0.0157
275 CANDIDA INFECTION 264 0.0156
276 BRAIN FOG 245 0.0156
277 BALANCE DISORDER 1348 0.0156
278 TENDERNESS 162 0.0155
279 BLOOD PRESSURE FLUCTUATION 371 0.0154
280 HAEMATOCRIT DECREASED 305 0.0154
281 INTERVERTEBRAL DISC DEGENERATION 142 0.0153
282 INSURANCE ISSUE 234 0.0153
283 CONSTIPATION 3337 0.0153
284 DRUG TOLERANCE 77 0.0152
285 PRODUCTIVE COUGH 726 0.0152
286 HYPERVOLAEMIA 75 0.0152
287 INSOMNIA 4036 0.0151
288 LIGAMENT SPRAIN 149 0.0151
289 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 82 0.0151
290 DECREASED APPETITE 3495 0.0150
291 ORTHOSTATIC HYPOTENSION 261 0.0150
292 RESPIRATORY TRACT CONGESTION 238 0.0150
293 FOOD POISONING 80 0.0149
294 DECREASED INTEREST 88 0.0149
295 PARAESTHESIA 2343 0.0149
296 HOT FLUSH 1117 0.0148
297 TOOTH INFECTION 195 0.0148
298 ARTHRITIS 1163 0.0148
299 BRONCHITIS 1093 0.0148
300 DERMATITIS CONTACT 168 0.0147
301 PHOTOPHOBIA 277 0.0147
302 RALES 85 0.0146
303 BACTERIAL INFECTION 272 0.0146
304 SPINAL OSTEOARTHRITIS 128 0.0146
305 SECRETION DISCHARGE 182 0.0145
306 DYSPNOEA EXERTIONAL 547 0.0145
307 NERVE COMPRESSION 134 0.0145
308 EAR DISCOMFORT 149 0.0145
309 AMNESIA 944 0.0145
310 FATIGUE 11293 0.0145
311 INFUSION SITE EXTRAVASATION 89 0.0143
312 URINE ODOUR ABNORMAL 84 0.0143
313 MUSCULOSKELETAL CHEST PAIN 221 0.0143
314 ULCER 227 0.0143
315 MIDDLE INSOMNIA 266 0.0142
316 CONCUSSION 110 0.0142
317 NASAL DRYNESS 89 0.0142
318 TROPONIN INCREASED 108 0.0142
319 CATARACT OPERATION 84 0.0141
320 PRODUCT USE ISSUE 2656 0.0141
321 BLOOD PRESSURE SYSTOLIC INCREASED 275 0.0141
322 VITAMIN D DEFICIENCY 137 0.0140
323 PULMONARY MASS 209 0.0140
324 BACK PAIN 3258 0.0140
325 DECUBITUS ULCER 114 0.0140
326 ORAL PAIN 313 0.0140
327 ASTHENIA 5253 0.0140
328 ABDOMINAL DISTENSION 1455 0.0139
329 ARTHRALGIA 5787 0.0139
330 HIATUS HERNIA 180 0.0139
331 POOR QUALITY SLEEP 299 0.0139
332 RESTLESS LEGS SYNDROME 252 0.0138
333 SARS-COV-2 TEST POSITIVE 183 0.0138
334 GINGIVAL PAIN 110 0.0138
335 EYE INFECTION 156 0.0138
336 GASTROENTERITIS VIRAL 249 0.0138
337 MASS 192 0.0137
338 HYPOTHYROIDISM 438 0.0137
339 ORAL CANDIDIASIS 180 0.0137
340 MENISCUS INJURY 84 0.0136
341 SPUTUM DISCOLOURED 129 0.0136
342 PLATELET COUNT INCREASED 177 0.0136
343 URINARY TRACT INFECTION 2309 0.0135
344 WRIST FRACTURE 162 0.0135
345 TENDON DISORDER 88 0.0135
346 LOCALISED INFECTION 326 0.0135
347 EYE DISCHARGE 140 0.0135
348 GAIT DISTURBANCE 2571 0.0134
349 GOUT 241 0.0134
350 SQUAMOUS CELL CARCINOMA OF SKIN 81 0.0134
351 POST PROCEDURAL INFECTION 109 0.0134
352 EXERCISE TOLERANCE DECREASED 77 0.0134
353 JOINT INJURY 285 0.0133
354 MACULAR DEGENERATION 159 0.0133
355 DIZZINESS POSTURAL 129 0.0133
356 PAIN IN EXTREMITY 3913 0.0133
357 CHEST PAIN 2443 0.0132
358 APHTHOUS ULCER 102 0.0131
359 RHINORRHOEA 849 0.0131
360 ARTERIOSCLEROSIS CORONARY ARTERY 87 0.0131
361 PHARYNGITIS STREPTOCOCCAL 142 0.0131
362 BLADDER DISORDER 130 0.0131
363 LIMB INJURY 353 0.0130
364 HEADACHE 8143 0.0130
365 GROIN PAIN 114 0.0130
366 TOOTHACHE 235 0.0130
367 LABORATORY TEST ABNORMAL 383 0.0130
368 SINUS HEADACHE 77 0.0129
369 HAEMOLYSIS 100 0.0129
370 NASAL CONGESTION 761 0.0129
371 MUSCLE STRAIN 112 0.0129
372 CHRONIC KIDNEY DISEASE 982 0.0129
373 PAIN 7919 0.0129
374 OXYGEN SATURATION DECREASED 724 0.0129
375 COVID-19 PNEUMONIA 152 0.0129
376 BLOOD COUNT ABNORMAL 195 0.0128
377 ORAL HERPES 250 0.0128
378 GINGIVITIS 69 0.0128
379 TOOTH FRACTURE 141 0.0128
380 PRODUCT FORMULATION ISSUE 84 0.0127
381 OSTEOPENIA 193 0.0127
382 ROTATOR CUFF SYNDROME 163 0.0127
383 DRY EYE 631 0.0126
384 DECREASED ACTIVITY 136 0.0126
385 TEMPERATURE INTOLERANCE 130 0.0126
386 POOR VENOUS ACCESS 130 0.0126
387 HOSPICE CARE 124 0.0125
388 FOREIGN BODY SENSATION IN EYES 80 0.0125
389 RASH 5467 0.0125
390 BREAST MASS 84 0.0125
391 FLATULENCE 709 0.0125
392 HEART RATE DECREASED 437 0.0124
393 HEAD DISCOMFORT 220 0.0124
394 FEEDING DISORDER 252 0.0124
395 RESPIRATORY TRACT INFECTION 323 0.0124
396 RIB FRACTURE 255 0.0124
397 PHARYNGITIS 153 0.0123
398 ABNORMAL LOSS OF WEIGHT 84 0.0123
399 DRY THROAT 125 0.0123
400 WEIGHT DECREASED 3431 0.0123
401 SKIN FISSURES 240 0.0123
402 ARTHROPOD BITE 91 0.0123
403 PARAESTHESIA ORAL 177 0.0123
404 SWELLING OF EYELID 77 0.0123
405 HEART RATE IRREGULAR 277 0.0122
406 PAIN IN JAW 346 0.0122
407 SENSITIVE SKIN 90 0.0122
408 ENERGY INCREASED 72 0.0122
409 BODY TEMPERATURE DECREASED 120 0.0122
410 TOOTH DISORDER 271 0.0122
411 JOINT EFFUSION 84 0.0122
412 CATARACT 724 0.0121
413 PERONEAL NERVE PALSY 69 0.0121
414 IMMUNE SYSTEM DISORDER 160 0.0121
415 FEELING HOT 744 0.0121
416 OROPHARYNGEAL PAIN 1121 0.0121
417 PNEUMONIA ASPIRATION 302 0.0121
418 CYST 150 0.0121
419 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 630 0.0121
420 APPETITE DISORDER 80 0.0121
421 WHITE BLOOD CELL COUNT ABNORMAL 77 0.0121
422 DYSSTASIA 352 0.0120
423 HERNIA 233 0.0120
424 MUSCLE TIGHTNESS 195 0.0120
425 SNEEZING 269 0.0120
426 BURNING SENSATION 841 0.0120
427 TOOTH ABSCESS 122 0.0120
428 PRODUCT DISTRIBUTION ISSUE 111 0.0120
429 DENTAL CARIES 132 0.0119
430 DIARRHOEA 7688 0.0119
431 BLOOD PRESSURE INCREASED 1820 0.0119
432 RECTAL HAEMORRHAGE 511 0.0119
433 INTERVERTEBRAL DISC PROTRUSION 260 0.0119
434 COVID-19 2086 0.0119
435 OEDEMA PERIPHERAL 1447 0.0119
436 RETCHING 252 0.0118
437 HERPES ZOSTER 679 0.0118
438 SENSORY LOSS 95 0.0118
439 AGEUSIA 294 0.0118
440 HAEMOGLOBIN DECREASED 1210 0.0118
441 MUSCULOSKELETAL DISORDER 224 0.0118
442 SLUGGISHNESS 120 0.0118
443 PLATELET COUNT ABNORMAL 71 0.0117
444 LYMPHOEDEMA 81 0.0117
445 BLOOD POTASSIUM INCREASED 190 0.0117
446 IRON DEFICIENCY ANAEMIA 108 0.0117
447 INTENTIONAL PRODUCT MISUSE 1022 0.0117
448 CONDITION AGGRAVATED 3546 0.0117
449 PRURITUS 4481 0.0116
450 DIZZINESS 5813 0.0116
451 BLOOD URINE PRESENT 221 0.0116
452 DEPRESSION 2648 0.0116
453 BOWEL MOVEMENT IRREGULARITY 89 0.0116
454 FOOT FRACTURE 220 0.0116
455 DYSPHONIA 677 0.0116
456 HAIR GROWTH ABNORMAL 80 0.0115
457 POLLAKIURIA 482 0.0115
458 POSTOPERATIVE WOUND INFECTION 78 0.0115
459 DIVERTICULITIS 320 0.0115
460 IMPAIRED QUALITY OF LIFE 166 0.0115
461 WHITE BLOOD CELL COUNT DECREASED 1251 0.0115
462 FACIAL PAIN 103 0.0115
463 APHONIA 161 0.0115
464 FALL 3839 0.0115
465 CARDIOGENIC SHOCK 165 0.0115
466 CLOSTRIDIUM DIFFICILE INFECTION 251 0.0115
467 BASAL CELL CARCINOMA 179 0.0115
468 NEUROPATHY PERIPHERAL 1091 0.0115
469 COUGH 3212 0.0114
470 INCONTINENCE 121 0.0114
471 WHITE BLOOD CELL COUNT INCREASED 439 0.0114
472 PNEUMONIA 3701 0.0114
473 BLOOD PRESSURE ABNORMAL 227 0.0114
474 COGNITIVE DISORDER 533 0.0114
475 THROAT IRRITATION 512 0.0114
476 SKIN INFECTION 128 0.0114
477 INITIAL INSOMNIA 117 0.0114
478 DIVERTICULUM 81 0.0114
479 PERIPHERAL COLDNESS 155 0.0113
480 MUSCULOSKELETAL DISCOMFORT 194 0.0113
481 NODULE 147 0.0113
482 LIMB DISCOMFORT 348 0.0112
483 TENDONITIS 174 0.0112
484 MITRAL VALVE INCOMPETENCE 127 0.0112
485 MUSCLE ATROPHY 142 0.0112
486 RASH PRURITIC 607 0.0112
487 PYREXIA 3871 0.0112
488 EATING DISORDER 238 0.0112
489 UROSEPSIS 103 0.0112
490 BONE PAIN 653 0.0111
491 OBSTRUCTIVE AIRWAYS DISORDER 124 0.0111
492 SCOLIOSIS 69 0.0111
493 CARDIAC FLUTTER 72 0.0111
494 SCAB 127 0.0111
495 SKIN HAEMORRHAGE 164 0.0111
496 ANAL INCONTINENCE 99 0.0110
497 HAIR TEXTURE ABNORMAL 147 0.0110
498 GINGIVAL BLEEDING 150 0.0110
499 HYSTERECTOMY 95 0.0110
500 ADVERSE DRUG REACTION 985 0.0110
501 SQUAMOUS CELL CARCINOMA 103 0.0109
502 BLOOD POTASSIUM DECREASED 329 0.0109
503 COLITIS ULCERATIVE 488 0.0109
504 THYROID DISORDER 168 0.0109
505 THERAPY CHANGE 107 0.0109
506 BLOOD SODIUM DECREASED 205 0.0109
507 HYPERSOMNIA 311 0.0108
508 TINNITUS 498 0.0108
509 CELLULITIS 546 0.0108
510 HYPERHIDROSIS 1394 0.0108
511 HIP FRACTURE 348 0.0108
512 NERVE INJURY 120 0.0108
513 HYPERTRANSAMINASAEMIA 75 0.0108
514 ASPIRATION 118 0.0108
515 SPLENOMEGALY 126 0.0107
516 THERAPY CESSATION 552 0.0107
517 ABNORMAL FAECES 88 0.0107
518 DYSPNOEA 6079 0.0107
519 PHARYNGEAL SWELLING 105 0.0107
520 FEELING COLD 298 0.0107
521 FUNGAL INFECTION 355 0.0106
522 HEART RATE INCREASED 1055 0.0106
523 RENAL DISORDER 495 0.0106
524 PAROSMIA 80 0.0106
525 EPISTAXIS 793 0.0106
526 ANXIETY 3012 0.0106
527 PROSTATIC SPECIFIC ANTIGEN INCREASED 145 0.0105
528 METASTASES TO LYMPH NODES 71 0.0105
529 VIRAL INFECTION 350 0.0105
530 ACUTE RESPIRATORY FAILURE 202 0.0105
531 VOMITING 4929 0.0105
532 SKIN ULCER 271 0.0105
533 ANKLE FRACTURE 162 0.0105
534 ATELECTASIS 101 0.0104
535 HYPOPHAGIA 267 0.0104
536 DEFAECATION URGENCY 73 0.0104
537 KIDNEY INFECTION 204 0.0104
538 LYMPHOCYTE COUNT DECREASED 183 0.0103
539 ADVERSE EVENT 954 0.0103
540 RENAL CYST 82 0.0103
541 INFLUENZA 1151 0.0103
542 HEPATITIS 264 0.0103
543 POST-TRAUMATIC STRESS DISORDER 69 0.0103
544 CLOSTRIDIUM DIFFICILE COLITIS 109 0.0103
545 URINARY INCONTINENCE 304 0.0103
546 THIRST 183 0.0102
547 BRONCHIECTASIS 69 0.0102
548 HAIR COLOUR CHANGES 127 0.0102
549 UPPER LIMB FRACTURE 203 0.0102
550 PURPURA 90 0.0102
551 LACRIMATION INCREASED 307 0.0102
552 SPINAL COMPRESSION FRACTURE 84 0.0101
553 PELVIC FRACTURE 79 0.0101
554 HEAD INJURY 321 0.0101
555 PRODUCT USE IN UNAPPROVED INDICATION 2508 0.0101
556 MALNUTRITION 113 0.0101
557 GLAUCOMA 194 0.0101
558 VITREOUS FLOATERS 99 0.0101
559 SKIN DISORDER 335 0.0100
560 GASTROINTESTINAL INFECTION 90 0.0100
561 IMPAIRED DRIVING ABILITY 114 0.0100
562 ATRIAL FLUTTER 80 0.0100
563 FRUSTRATION TOLERANCE DECREASED 81 0.0100
564 SKIN DISCOLOURATION 459 0.0100
565 PRODUCT DOSE OMISSION IN ERROR 282 0.0099
566 ABDOMINAL PAIN 2315 0.0099
567 EYE IRRITATION 572 0.0099
568 ASCITES 292 0.0099
569 NAUSEA 7853 0.0099
570 FLANK PAIN 93 0.0099
571 HEREDITARY ANGIOEDEMA 106 0.0099
572 IMPAIRED WORK ABILITY 211 0.0099
573 FEELING JITTERY 188 0.0099
574 ORAL DISORDER 72 0.0098
575 CHILLS 1151 0.0098
576 LOW DENSITY LIPOPROTEIN INCREASED 76 0.0098
577 GALLBLADDER DISORDER 175 0.0098
578 SCRATCH 103 0.0098
579 NEPHROLITHIASIS 447 0.0097
580 SKIN LESION 267 0.0097
581 SKIN CANCER 209 0.0097
582 CHEST DISCOMFORT 992 0.0097
583 ILLNESS 997 0.0097
584 ERUCTATION 187 0.0097
585 BONE DISORDER 176 0.0096
586 PLATELET COUNT DECREASED 1026 0.0096
587 NASAL DISCOMFORT 76 0.0096
588 ARTERIOSCLEROSIS 90 0.0096
589 VISUAL IMPAIRMENT 1184 0.0095
590 PULMONARY THROMBOSIS 104 0.0095
591 MALAISE 4166 0.0095
592 DYSGEUSIA 705 0.0095
593 CHROMATURIA 214 0.0095
594 THROMBOSIS 762 0.0095
595 BREAST PAIN 101 0.0095
596 CEREBRAL DISORDER 70 0.0095
597 OCULAR HYPERAEMIA 447 0.0094
598 RASH MACULAR 329 0.0094
599 CORONARY ARTERY OCCLUSION 129 0.0094
600 SPINAL DISORDER 89 0.0094
601 DEHYDRATION 1253 0.0094
602 PHOTOSENSITIVITY REACTION 155 0.0094
603 ATRIAL FIBRILLATION 914 0.0094
604 HYPERAESTHESIA 77 0.0094
605 FEELING ABNORMAL 2236 0.0093
606 MALIGNANT MELANOMA 125 0.0093
607 NEPHROPATHY 87 0.0093
608 TENDON RUPTURE 115 0.0093
609 ARTERIAL OCCLUSIVE DISEASE 73 0.0093
610 RENAL PAIN 98 0.0092
611 SEDATION 241 0.0092
612 VAGINAL DISCHARGE 93 0.0092
613 SMALL INTESTINAL OBSTRUCTION 113 0.0092
614 UNDERDOSE 670 0.0092
615 MEDICATION ERROR 510 0.0092
616 MYALGIA 1558 0.0092
617 HYPOAESTHESIA ORAL 138 0.0091
618 PSORIASIS 1193 0.0091
619 DIPLOPIA 237 0.0091
620 OSTEOMYELITIS 165 0.0091
621 OROPHARYNGEAL DISCOMFORT 82 0.0091
622 GASTROINTESTINAL INFLAMMATION 71 0.0091
623 FAECES DISCOLOURED 196 0.0090
624 EYE DISORDER 296 0.0090
625 HAIR DISORDER 74 0.0090
626 HAEMOPTYSIS 250 0.0090
627 THERAPEUTIC RESPONSE UNEXPECTED 402 0.0090
628 VISION BLURRED 1227 0.0089
629 TRICUSPID VALVE INCOMPETENCE 71 0.0089
630 HAEMORRHOIDS 174 0.0089
631 ANOSMIA 129 0.0089
632 MULTIPLE FRACTURES 146 0.0089
633 PALPITATIONS 1040 0.0089
634 INTENTIONAL DOSE OMISSION 253 0.0089
635 DYSURIA 326 0.0088
636 SPINAL OPERATION 109 0.0088
637 PANIC ATTACK 322 0.0088
638 SCAR 151 0.0088
639 SKIN SWELLING 76 0.0087
640 POST PROCEDURAL COMPLICATION 168 0.0087
641 COORDINATION ABNORMAL 122 0.0087
642 SPINAL FRACTURE 175 0.0087
643 EYE SWELLING 324 0.0087
644 OESOPHAGITIS 95 0.0087
645 SOMNOLENCE 1745 0.0087
646 INJECTION SITE REACTION 596 0.0087
647 OFF LABEL USE 7568 0.0086
648 ERYTHEMA 1770 0.0086
649 PULMONARY HYPERTENSION 179 0.0086
650 TRANSIENT ISCHAEMIC ATTACK 289 0.0086
651 RHINITIS 69 0.0085
652 FLUSHING 869 0.0085
653 HAEMATOCHEZIA 470 0.0085
654 IMPAIRED GASTRIC EMPTYING 116 0.0085
655 PRODUCT USE COMPLAINT 134 0.0085
656 PULMONARY CONGESTION 112 0.0085
657 VERTIGO 515 0.0084
658 RESPIRATORY RATE INCREASED 75 0.0084
659 DRY SKIN 1127 0.0084
660 EMPHYSEMA 85 0.0084
661 PRODUCT SUBSTITUTION ISSUE 485 0.0084
662 PSEUDOMONAS INFECTION 72 0.0084
663 TREMOR 1392 0.0084
664 EYE INFLAMMATION 80 0.0084
665 HEPATIC STEATOSIS 156 0.0084
666 SPINAL PAIN 98 0.0084
667 LETHARGY 481 0.0084
668 PETECHIAE 87 0.0083
669 SKIN EXFOLIATION 701 0.0083
670 LACERATION 78 0.0083
671 BEDRIDDEN 109 0.0083
672 BLOOD PRESSURE DECREASED 551 0.0083
673 PRODUCT QUALITY ISSUE 1125 0.0083
674 UPPER GASTROINTESTINAL HAEMORRHAGE 139 0.0083
675 MOVEMENT DISORDER 265 0.0082
676 EYE PRURITUS 276 0.0082
677 TRANSFUSION 86 0.0082
678 PRODUCT DOSE OMISSION ISSUE 2413 0.0082
679 VENTRICULAR EXTRASYSTOLES 85 0.0082
680 RESPIRATORY DEPRESSION 100 0.0082
681 INTERNAL HAEMORRHAGE 93 0.0081
682 KNEE OPERATION 80 0.0081
683 PLEURAL EFFUSION 494 0.0081
684 THERAPY INTERRUPTED 580 0.0081
685 CARDIAC DISORDER 758 0.0081
686 PROCEDURAL PAIN 224 0.0081
687 MULTIPLE SCLEROSIS 386 0.0081
688 MULTIPLE SCLEROSIS RELAPSE 553 0.0081
689 INFLUENZA LIKE ILLNESS 661 0.0080
690 MULTIPLE ORGAN DYSFUNCTION SYNDROME 227 0.0080
691 URINE OUTPUT DECREASED 70 0.0080
692 ANAEMIA 1526 0.0080
693 COLD SWEAT 141 0.0080
694 PRESYNCOPE 194 0.0080
695 LYMPHADENOPATHY 281 0.0079
696 SPEECH DISORDER 415 0.0079
697 QUALITY OF LIFE DECREASED 106 0.0079
698 SEPSIS 881 0.0079
699 MOTOR DYSFUNCTION 80 0.0078
700 BRAIN OEDEMA 99 0.0078
701 ABSCESS 125 0.0078
702 STAPHYLOCOCCAL INFECTION 257 0.0078
703 RASH PAPULAR 174 0.0078
704 FEMUR FRACTURE 240 0.0077
705 HALLUCINATION 582 0.0077
706 INTESTINAL OBSTRUCTION 291 0.0077
707 NEUTROPHIL COUNT INCREASED 79 0.0077
708 DIARRHOEA HAEMORRHAGIC 72 0.0077
709 NERVOUSNESS 402 0.0077
710 DEPRESSED MOOD 406 0.0077
711 ABNORMAL DREAMS 212 0.0077
712 PNEUMONIA BACTERIAL 70 0.0076
713 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1374 0.0076
714 SENSORY DISTURBANCE 122 0.0076
715 THERAPEUTIC RESPONSE DECREASED 458 0.0075
716 TOOTH EXTRACTION 94 0.0075
717 THERAPEUTIC RESPONSE SHORTENED 250 0.0075
718 DISTURBANCE IN ATTENTION 406 0.0075
719 GASTRITIS 198 0.0075
720 BLOOD ALKALINE PHOSPHATASE INCREASED 186 0.0075
721 DYSPHAGIA 710 0.0075
722 DEAFNESS 195 0.0074
723 ECZEMA 389 0.0074
724 CHOKING 145 0.0074
725 HYPONATRAEMIA 418 0.0074
726 COLITIS 281 0.0074
727 CONJUNCTIVITIS 137 0.0074
728 CHOLECYSTECTOMY 84 0.0073
729 INABILITY TO AFFORD MEDICATION 73 0.0073
730 CHOLELITHIASIS 241 0.0073
731 ORAL DISCOMFORT 102 0.0073
732 HYPOTENSION 1465 0.0073
733 FISTULA 82 0.0073
734 MUSCLE TWITCHING 168 0.0073
735 SURGERY 427 0.0073
736 THROMBOCYTOPENIA 814 0.0073
737 DEMENTIA 203 0.0073
738 APHASIA 219 0.0072
739 GLOMERULAR FILTRATION RATE DECREASED 89 0.0072
740 HYPOXIA 254 0.0072
741 INJECTION SITE DISCOLOURATION 90 0.0072
742 DRUG EFFECT LESS THAN EXPECTED 106 0.0071
743 GASTRIC DISORDER 245 0.0071
744 UNEVALUABLE EVENT 539 0.0071
745 RESTLESSNESS 259 0.0071
746 PANCREATITIS 374 0.0071
747 ANGER 239 0.0071
748 SWELLING FACE 460 0.0071
749 THROAT TIGHTNESS 191 0.0071
750 PERICARDIAL EFFUSION 163 0.0070
751 PULMONARY ARTERIAL HYPERTENSION 102 0.0070
752 NEOPLASM PROGRESSION 243 0.0070
753 FEAR 187 0.0069
754 ACCIDENT 83 0.0069
755 MOUTH ULCERATION 146 0.0069
756 THINKING ABNORMAL 129 0.0069
757 DELUSION 107 0.0069
758 NEOPLASM 79 0.0069
759 APATHY 100 0.0068
760 ADRENAL INSUFFICIENCY 83 0.0068
761 BLOOD UREA INCREASED 114 0.0068
762 BIPOLAR DISORDER 74 0.0068
763 DYSARTHRIA 256 0.0068
764 HUNGER 94 0.0067
765 CARDIOMEGALY 83 0.0067
766 CRYING 245 0.0067
767 MADAROSIS 78 0.0067
768 NEUTROPHIL COUNT DECREASED 273 0.0067
769 INCORRECT PRODUCT ADMINISTRATION DURATION 145 0.0067
770 DYSKINESIA 272 0.0067
771 PRURITUS GENERALISED 144 0.0067
772 INCREASED APPETITE 127 0.0066
773 HOSPITALISATION 1016 0.0066
774 PULMONARY OEDEMA 295 0.0066
775 CORONARY ARTERY DISEASE 199 0.0066
776 URINARY RETENTION 219 0.0066
777 PRODUCT PRESCRIBING ERROR 156 0.0065
778 DERMATITIS 137 0.0065
779 NIGHTMARE 226 0.0065
780 LUNG INFECTION 101 0.0065
781 PRODUCT AVAILABILITY ISSUE 148 0.0065
782 HYPOKINESIA 94 0.0065
783 VASCULITIS 75 0.0064
784 INJECTION SITE BRUISING 512 0.0064
785 HYPOACUSIS 274 0.0064
786 BLOOD CREATININE INCREASED 415 0.0063
787 TACHYCARDIA 564 0.0063
788 CENTRAL NERVOUS SYSTEM LESION 87 0.0063
789 BACTERAEMIA 75 0.0063
790 DEPRESSED LEVEL OF CONSCIOUSNESS 250 0.0063
791 SKIN REACTION 89 0.0063
792 HEMIPARESIS 107 0.0063
793 ACTIVITIES OF DAILY LIVING IMPAIRED 125 0.0063
794 METASTASES TO BONE 103 0.0063
795 DISEASE RECURRENCE 298 0.0063
796 DEVICE OCCLUSION 88 0.0062
797 CARDIAC FAILURE CONGESTIVE 502 0.0062
798 EYE HAEMORRHAGE 83 0.0062
799 PLASMA CELL MYELOMA 241 0.0062
800 PNEUMOTHORAX 97 0.0061
801 SWOLLEN TONGUE 191 0.0061
802 POST PROCEDURAL HAEMORRHAGE 71 0.0061
803 BLINDNESS UNILATERAL 86 0.0061
804 MOOD SWINGS 194 0.0061
805 LOCAL SWELLING 106 0.0061
806 PULMONARY EMBOLISM 577 0.0061
807 PRODUCT DOSE OMISSION 396 0.0061
808 MENTAL IMPAIRMENT 147 0.0061
809 LOSS OF CONSCIOUSNESS 774 0.0060
810 PAIN OF SKIN 162 0.0060
811 HALLUCINATION, VISUAL 127 0.0060
812 LIP SWELLING 200 0.0060
813 RENAL FAILURE 794 0.0060
814 DIABETES MELLITUS 455 0.0060
815 PRODUCT PHYSICAL ISSUE 120 0.0059
816 ACUTE KIDNEY INJURY 909 0.0059
817 ELECTROLYTE IMBALANCE 69 0.0059
818 ABDOMINAL PAIN LOWER 150 0.0059
819 EMOTIONAL DISORDER 182 0.0059
820 IRRITABILITY 354 0.0059
821 DEEP VEIN THROMBOSIS 381 0.0059
822 TREATMENT NONCOMPLIANCE 319 0.0058
823 ATAXIA 69 0.0058
824 LEUKOCYTOSIS 105 0.0058
825 PARANOIA 100 0.0058
826 PELVIC PAIN 105 0.0058
827 SYNCOPE 578 0.0058
828 BLOOD TRIGLYCERIDES INCREASED 102 0.0058
829 GASTROINTESTINAL HAEMORRHAGE 482 0.0058
830 COAGULOPATHY 96 0.0058
831 DRUG INEFFECTIVE 7523 0.0057
832 DISORIENTATION 225 0.0057
833 ACNE 430 0.0057
834 SKIN IRRITATION 259 0.0056
835 PRODUCT ADMINISTRATION ERROR 113 0.0056
836 INJECTION SITE RASH 170 0.0055
837 PRODUCT TASTE ABNORMAL 75 0.0055
838 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 394 0.0055
839 COMA 263 0.0055
840 BONE DENSITY DECREASED 173 0.0055
841 COMPLICATION ASSOCIATED WITH DEVICE 80 0.0055
842 METASTASES TO CENTRAL NERVOUS SYSTEM 71 0.0055
843 GASTRIC ULCER 104 0.0055
844 ASPARTATE AMINOTRANSFERASE INCREASED 290 0.0055
845 INJECTION SITE MASS 201 0.0054
846 ABASIA 134 0.0054
847 ERECTILE DYSFUNCTION 139 0.0054
848 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 125 0.0054
849 FLUID OVERLOAD 78 0.0054
850 PALLOR 145 0.0053
851 SEIZURE 614 0.0053
852 HAEMORRHAGE 555 0.0053
853 ANHEDONIA 139 0.0053
854 MOOD ALTERED 143 0.0052
855 DEVICE RELATED INFECTION 80 0.0052
856 INJECTION SITE PRURITUS 348 0.0052
857 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 283 0.0052
858 HAEMATURIA 176 0.0051
859 MENTAL STATUS CHANGES 142 0.0051
860 ANGINA PECTORIS 146 0.0051
861 VAGINAL HAEMORRHAGE 220 0.0051
862 HAEMATOMA 131 0.0051
863 LEUKOPENIA 252 0.0050
864 THERAPY PARTIAL RESPONDER 78 0.0050
865 APPLICATION SITE PAIN 110 0.0050
866 ARRHYTHMIA 236 0.0050
867 SKIN BURNING SENSATION 355 0.0050
868 EJECTION FRACTION DECREASED 77 0.0049
869 WITHDRAWAL SYNDROME 206 0.0049
870 DRUG DOSE OMISSION 806 0.0049
871 PHARYNGEAL OEDEMA 75 0.0049
872 ALANINE AMINOTRANSFERASE INCREASED 299 0.0049
873 DISEASE PROGRESSION 576 0.0049
874 INJECTION SITE URTICARIA 119 0.0048
875 UNRESPONSIVE TO STIMULI 125 0.0048
876 BRONCHOSPASM 69 0.0048
877 ECONOMIC PROBLEM 73 0.0048
878 APPLICATION SITE PRURITUS 109 0.0048
879 DERMATITIS ATOPIC 253 0.0048
880 BLOOD GLUCOSE DECREASED 230 0.0048
881 MENTAL DISORDER 208 0.0048
882 INJECTION SITE ERYTHEMA 591 0.0048
883 DRUG EFFECT INCOMPLETE 172 0.0047
884 BONE LOSS 71 0.0047
885 AGITATION 346 0.0047
886 RENAL IMPAIRMENT 393 0.0047
887 GLYCOSYLATED HAEMOGLOBIN INCREASED 118 0.0047
888 CYANOSIS 73 0.0046
889 PSYCHOMOTOR HYPERACTIVITY 77 0.0046
890 INJECTION SITE PAIN 1421 0.0046
891 INJECTION SITE SWELLING 350 0.0046
892 INJECTION SITE HAEMORRHAGE 364 0.0046
893 RENAL INJURY 135 0.0045
894 RESPIRATORY DISTRESS 125 0.0045
895 HYPOKALAEMIA 208 0.0045
896 EXPIRED PRODUCT ADMINISTERED 149 0.0045
897 PNEUMONITIS 122 0.0045
898 LYMPHOMA 69 0.0045
899 PRODUCT PRESCRIBING ISSUE 97 0.0044
900 APPLICATION SITE ERYTHEMA 116 0.0044
901 SUICIDAL IDEATION 405 0.0044
902 HAEMATEMESIS 112 0.0044
903 EXPOSURE VIA SKIN CONTACT 114 0.0044
904 INTERNATIONAL NORMALISED RATIO INCREASED 124 0.0043
905 BRADYCARDIA 230 0.0043
906 NEEDLE ISSUE 126 0.0043
907 DEVICE ISSUE 383 0.0043
908 ACCIDENTAL OVERDOSE 156 0.0043
909 CEREBROVASCULAR ACCIDENT 719 0.0042
910 INCORRECT DRUG ADMINISTRATION DURATION 119 0.0042
911 OVERDOSE 912 0.0042
912 BLOOD GLUCOSE INCREASED 795 0.0042
913 INCORRECT DOSE ADMINISTERED 961 0.0042
914 FRACTURE 79 0.0042
915 BLINDNESS 169 0.0041
916 EXTRA DOSE ADMINISTERED 167 0.0041
917 DEVICE USE ISSUE 72 0.0041
918 RESPIRATORY FAILURE 300 0.0041
919 TOOTH LOSS 85 0.0041
920 LIVER FUNCTION TEST ABNORMAL 119 0.0041
921 HYPERGLYCAEMIA 148 0.0041
922 BLOOD GLUCOSE ABNORMAL 75 0.0041
923 MALIGNANT NEOPLASM PROGRESSION 415 0.0040
924 OSTEONECROSIS OF JAW 100 0.0040
925 BLOOD BILIRUBIN INCREASED 108 0.0040
926 NEOPLASM MALIGNANT 266 0.0040
927 RASH GENERALISED 103 0.0040
928 ANAPHYLACTIC REACTION 218 0.0039
929 DRUG EFFECT DECREASED 211 0.0039
930 TRANSAMINASES INCREASED 86 0.0039
931 FEBRILE NEUTROPENIA 255 0.0038
932 INJECTION SITE WARMTH 79 0.0038
933 ENCEPHALOPATHY 94 0.0038
934 VISUAL ACUITY REDUCED 127 0.0038
935 GAMMA-GLUTAMYLTRANSFERASE INCREASED 84 0.0038
936 CEREBRAL HAEMORRHAGE 135 0.0038
937 PRODUCT DISPENSING ERROR 82 0.0038
938 NEUTROPENIA 505 0.0037
939 HEPATOTOXICITY 81 0.0036
940 PROTEINURIA 69 0.0036
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 729 0.0036
942 CARDIAC FAILURE 285 0.0035
943 MENORRHAGIA 69 0.0035
944 DRUG INTERACTION 551 0.0035
945 ACUTE MYOCARDIAL INFARCTION 102 0.0035
946 MELAENA 76 0.0034
947 NERVOUS SYSTEM DISORDER 107 0.0034
948 DEATH 2939 0.0034
949 JAUNDICE 91 0.0034
950 HYPOGLYCAEMIA 162 0.0033
951 PANCYTOPENIA 186 0.0033
952 LUNG NEOPLASM MALIGNANT 132 0.0032
953 AGGRESSION 159 0.0032
954 CARDIOVASCULAR DISORDER 80 0.0031
955 SEPTIC SHOCK 137 0.0031
956 MYOCARDIAL INFARCTION 543 0.0031
957 ABNORMAL BEHAVIOUR 123 0.0031
958 DEVICE DISLOCATION 134 0.0031
959 FOETAL EXPOSURE DURING PREGNANCY 249 0.0031
960 PSYCHOTIC DISORDER 90 0.0030
961 BLOOD CREATINE PHOSPHOKINASE INCREASED 86 0.0030
962 DEVICE MALFUNCTION 202 0.0029
963 MENSTRUATION IRREGULAR 75 0.0028
964 HEPATIC FAILURE 83 0.0028
965 EMOTIONAL DISTRESS 330 0.0027
966 INTERSTITIAL LUNG DISEASE 131 0.0027
967 ANAPHYLACTIC SHOCK 68 0.0026
968 CARDIAC ARREST 215 0.0026
969 BREAST CANCER 240 0.0026
970 WRONG TECHNIQUE IN DRUG USAGE PROCESS 93 0.0026
971 MYELOSUPPRESSION 91 0.0025
972 RENAL FAILURE ACUTE 107 0.0025
973 HYPERKALAEMIA 88 0.0025
974 DRUG ADMINISTRATION ERROR 74 0.0024
975 DEVICE BREAKAGE 94 0.0023
976 DEVICE LEAKAGE 99 0.0023
977 ABORTION SPONTANEOUS 89 0.0022
978 PRODUCT ADHESION ISSUE 79 0.0022
979 ELECTROCARDIOGRAM QT PROLONGED 79 0.0022
980 ACCIDENTAL EXPOSURE TO PRODUCT 218 0.0021
981 OSTEONECROSIS 69 0.0021
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 92 0.0020
983 TOXICITY TO VARIOUS AGENTS 302 0.0018
984 NO ADVERSE EVENT 311 0.0017
985 PRODUCT STORAGE ERROR 150 0.0017
986 CARDIO-RESPIRATORY ARREST 70 0.0017
987 DRUG ABUSE 134 0.0016
988 PROSTATE CANCER 127 0.0016
989 ANGIOEDEMA 68 0.0015
990 DRUG WITHDRAWAL SYNDROME 132 0.0015
991 DEVICE DIFFICULT TO USE 93 0.0014
992 CONVULSION 77 0.0013
993 DRUG DEPENDENCE 170 0.0011